Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
Author Jerzy Świerkot
Pembrolizumab-induced arthritis in a patient with pulmonary adenocarcinoma
Reumatologia 2024;62/4 (Suppl 1)(XXV KONGRES POLSKIEGO TOWARZYSTWA REUMATOLOGICZNEGO ):127
Editor's Choice
EXPERT OPINION
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Żuber, Krzysztof Tomasiewicz
Reumatologia 2024;62(1):4-17
REVIEW PAPER
Rheumatoid arthritis – medication dosage in chronic kidney disease
Reumatologia 2023;61(6):481-491
ORIGINAL PAPER
The importance of ultrasound examination in early arthritis
Reumatologia 2018;56(6):354-361
REVIEW PAPER
Biosimilar switching – current state of knowledge
Piotr Wiland, Bogdan Batko, Marek Brzosko, Eugeniusz J. Kucharz, Włodzimierz Samborski, Jerzy Świerkot, Ewa Więsik-Szewczyk, Julia Feldman
Reumatologia 2018;56(4):234-242
ORIGINAL PAPER
Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice
Reumatologia 2018;56(1):3-9
ORIGINAL PAPER
Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation
Zofia Guła, Tacjana Barczyńska, Marek Brzosko, Jerzy Gąsowski, Sławomir Jeka, Katarzyna Jodłowska-Cicio, Beata Kwaśny-Krochin, Piotr Leszczyński, Łukasz Lubiński, Katarzyna Łosińska, Katarzyna Pawlak-Buś, Hanna Przepiera-Będzak, Włodzimierz Samborski, Małgorzata Schlabs, Maciej Siedlar, Dorota Sikorska, Jerzy Świerkot, Małgorzata Węgierska, Piotr Wiland, Mariusz Korkosz
Reumatologia 2017;55(2):59-64
Cytokine profiles in axial spondyloarthritis
Marta Madej, Beata Nowak, Jerzy Świerkot, Renata Sokolik, Arkadiusz Chlebicki, Lucyna Korman, Patryk Woytala, Łukasz Lubiński, Piotr Wiland
Reumatologia 2015;53(1):9-13
GUIDELINES
Psoriatic arthritis
Reumatologia 2016;(Aktualizacja zaleceń postępowania diagnostyczno-terapeutycznego w chorobach reumatycznych na podstawie rekomendacji EULAR/ACR 1):22-25
GUIDELINES
Ankylosing spondylitis and axial spondyloarthropathy
Reumatologia 2016;(Aktualizacja zaleceń postępowania diagnostyczno-terapeutycznego w chorobach reumatycznych na podstawie rekomendacji EULAR/ACR 1):15-21
ORIGINAL PAPER
A 6-month trial assessing the safety and efficacy of cyclosporine treatment in patients with active rheumatoid arthritis
Reumatologia 2005;43(5):257-264
The safety and efficacy of adalimumab for the treatment of ankylosing spondylitis (AS) and active psoriatic arthritis (PsA) in patients in a 16-week study
Reumatologia 2007;45(5):248-257
Orginal paper
Efficacy and safety of adalimumab in treatment of patients with rheumatoid arthritis
Reumatologia 2007;45(5):241-247
Subcutaneous methotrexate injection in the treatment of rheumatoid arthritis
Reumatologia 2007;45(6):407-414
REVIEW PAPER
Adalimumab – the first fully human monoclonal antibody used in the treatment of rheumatoid arthritis
Jacek Szechiński, Sławomir Jeka, Krzysztof Borysewicz, Anna Filipowicz-Sosnowska, Katarzyna Kolossa, Eugeniusz J. Kucharz, Beata Nowak, Jerzy Świerkot, Piotr Wiland
Reumatologia 2008;46(3):151-158
Original paper
Clinical efficacy and safety of oral versus subcutaneous administration of methotrexate in patients with rheumatoid arthritis
Jerzy Świerkot, Renata Sokolik, Katarzyna Gruszecka-Marczyńska, Ryszard Międzybrodzki, Jacek Szechiński
Reumatologia 2008;46(6):322-329
ORIGINAL PAPER
Effect of methylenetetrahydrofolate reductase polymorphism on toxicity and efficacy of methotrexate in patients with rheumatoid arthritis
Jerzy Świerkot, Ryszard Ślęzak, Paweł Karpiński, Justyna Pawłowska, Leszek Noga, Jacek Szechiński, Piotr Wiland
Reumatologia 2010;48(2):81-93
REVIEW PAPER
Certolizumab pegol in the treatment of rheumatoid arthritis
Reumatologia 2011;49(4):253-263
CASE REPORT
Lung tuberculosis in a patient suffering from granulomatosis with polyangiitis (Wegener's granulomatosis) and receiving immunosuppressive treatment
Reumatologia 2013;51(2):156-160
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
